Translational research and innovation systems in health: implications on the biopharmaceutical segment

Abstract

The analysis of the dynamics of innovation in health in the context of the National System of Innovation in Health reveals the potential of the articulation of ST & I institutions with the Economic and Industrial Complex of Health (CEIS), in view of the interactions between universities and research institutes with the productive sector. Translational health research depends heavily on the dynamics and relative situation of CEIS in Brazil vis-à-vis the international context. The study analyzes, based in data extracted from the CNPq Research Groups Directory (DGP-CNPq), the interactions between pharmaceutical companies and health research groups in the country. The study shows the presence of a network of interactions with the productive sector in the biopharmaceutical area and highlights the potential of several Brazilian ST & I institutions to foster the development of the health innovation system. This interaction may acquire a translational perspective for the use of technological knowledge by Brazilian society insofar as it is articulated with the deepening of the CEIS development policy as a critical link to meet the demands of the Unified Health System.